Short takes: Option Care, Medicine Shoppe
By HME News Staff
Updated Wed September 6, 2017
Bannockburn, Ill.-based Option Care, an independent provider of home and alternate treatment site infusion services, has signed an agreement to become a national contracted provider of Radicava, an IV infusion treatment for ALS. Radicava is the first ALS treatment option approved by the U.S. Food and Drug Administration in more than 20 years. Option Care says its national payer network includes contracts with more than 800 health plans, ensuring broad access to the treatment…After more than two years of planning, the new Medicine Shoppe Pharmacy in DuQuoin, Ill., is near completion, according to the Harrisburg Register. The 3,000-square-foot pharmacy, which will also carry DME, is expected to open in the next two months with added features like drive-up windows and better parking.
Comments